Detalhe da pesquisa
1.
Genomic ancestry in kidney cancer: Correlations with clinical and molecular features.
Cancer
; 130(5): 692-701, 2024 03 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-37864521
2.
The impact of immunosuppressive agents on immune checkpoint inhibitor efficacy in patients with advanced melanoma: A real-world, multicenter, retrospective study.
Cancer
; 129(12): 1885-1894, 2023 06 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-36951119
3.
The Risk of Opportunistic Infections and the Role of Antibiotic Prophylaxis in Patients on Checkpoint Inhibitors Requiring Steroids.
J Natl Compr Canc Netw
; 20(7): 800-807.e1, 2022 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-35830888
4.
Dermatologic immune-related adverse events to checkpoint inhibitors in cancer.
J Allergy Clin Immunol
; 151(2): 407-409, 2023 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-36463979
5.
Immune tolerance with combined allogeneic haplo-identical haematopoietic stem cell transplant and renal transplant.
Br J Haematol
; 194(4): 779-783, 2021 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-34137024
6.
Artificial Intelligence-Assisted Cancer Status Detection in Radiology Reports.
Cancer Res Commun
; 4(4): 1041-1049, 2024 Apr 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-38592452
7.
Cabozantinib Plus Nivolumab in Patients with Non-Clear Cell Renal Cell Carcinoma: Updated Results from a Phase 2 Trial.
Eur Urol
; 2024 May 22.
Artigo
em Inglês
| MEDLINE | ID: mdl-38782695
8.
IL12/23 Blockade with Ustekinumab as a Treatment for Immune-Related Cutaneous Adverse Events.
Pharmaceuticals (Basel)
; 16(11)2023 Nov 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-38004414
9.
Real-world clinical outcomes of patients with metastatic renal cell carcinoma receiving pembrolizumabâ¯+â¯axitinib vs. ipilimumabâ¯+â¯nivolumab.
Urol Oncol
; 41(11): 459.e1-459.e8, 2023 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-37722984
10.
Progression-free Survival After Second Line of Therapy for Metastatic Clear Cell Renal Cell Carcinoma in Patients Treated with First-line Immunotherapy Combinations.
Eur Urol
; 83(3): 195-199, 2023 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-36344318
11.
Real-world Treatment Patterns and Clinical Outcomes for Metastatic Renal Cell Carcinoma in the Current Treatment Era.
Eur Urol Open Sci
; 49: 110-118, 2023 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-36874600
12.
A Phase 2 Trial of Talazoparib and Avelumab in Genomically Defined Metastatic Kidney Cancer.
Eur Urol Oncol
; 2023 Nov 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-37945488
13.
Safety and Activity of Immune Checkpoint Inhibitors in People Living With HIV and Cancer: A Real-World Report From the Cancer Therapy Using Checkpoint Inhibitors in People Living With HIV-International (CATCH-IT) Consortium.
J Clin Oncol
; 41(21): 3712-3723, 2023 07 20.
Artigo
em Inglês
| MEDLINE | ID: mdl-37192435
14.
Correction: Zhang et al. Association between Body Mass Index and Immune-Related Adverse Events (irAEs) among Advanced-Stage Cancer Patients Receiving Immune Checkpoint Inhibitors: A Pan-Cancer Analysis. Cancers 2021, 13, 6109.
Cancers (Basel)
; 14(18)2022 Sep 19.
Artigo
em Inglês
| MEDLINE | ID: mdl-36139703
15.
Contribution of the Skin-Gut Axis to Immune-Related Adverse Events with Multi-System Involvement.
Cancers (Basel)
; 14(12)2022 Jun 17.
Artigo
em Inglês
| MEDLINE | ID: mdl-35740660
16.
Phase II Trial of Cabozantinib Plus Nivolumab in Patients With Non-Clear-Cell Renal Cell Carcinoma and Genomic Correlates.
J Clin Oncol
; 40(21): 2333-2341, 2022 07 20.
Artigo
em Inglês
| MEDLINE | ID: mdl-35298296
17.
The Impact of Androgen Deprivation Therapy on COVID-19 Illness in Men With Prostate Cancer.
JNCI Cancer Spectr
; 6(3)2022 05 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-35657341
18.
Matched Molecular Profiling of Cell-Free DNA and Tumor Tissue in Patients With Advanced Clear Cell Renal Cell Carcinoma.
JCO Precis Oncol
; 6: e2200012, 2022 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-35797508
19.
Automated Identification of Patients With Immune-Related Adverse Events From Clinical Notes Using Word Embedding and Machine Learning.
JCO Clin Cancer Inform
; 5: 541-549, 2021 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-33989017
20.
Association between Body Mass Index and Immune-Related Adverse Events (irAEs) among Advanced-Stage Cancer Patients Receiving Immune Checkpoint Inhibitors: A Pan-Cancer Analysis.
Cancers (Basel)
; 13(23)2021 Dec 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-34885219